We are live on ! Find out more
KCM

Kennedy Capital Management Portfolio holdings

AUM $4.72B
1-Year Est. Return 36.69%
This Fund
S&P 500
This Quarter Est. Return
+2.94%
1 Year Est. Return
+36.69%
3 Year Est. Return
+98.85%
5 Year Est. Return
+128.89%
10 Year Est. Return
+548.51%
AUM
$4.5B
AUM Growth
-$26.3M
Cap. Flow
-$36.9M
Cap. Flow %
-0.82%
Top 10 Hldgs %
8.67%
Holding
752
New
65
Increased
220
Reduced
377
Closed
83

Top Buys

Rank Stock Value
1
BOOT icon
Boot Barn
BOOT
+$17.2M
2
UPBD icon
Upbound Group
UPBD
+$10.9M
3
MRCY icon
Mercury Systems
MRCY
+$10.6M
4
KMPR icon
Kemper
KMPR
+$9.56M
5
ESAB icon
ESAB
ESAB
+$8.84M

Top Sells

Rank Stock Value
1
SF
Stifel
SF
+$19.5M
2
SHOO icon
Steven Madden
SHOO
+$17.6M
3
PHAT icon
Phathom Pharmaceuticals
PHAT
+$13.2M
4
B
Barnes Group Inc.
B
+$13.2M
5
WTFC icon
Wintrust Financial
WTFC
+$11M

Sector Composition

Rank Sector Weight
1 Financials 20.83%
2 Industrials 18.44%
3 Healthcare 17.49%
4 Technology 13.76%
5 Consumer Discretionary 7.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SKYW icon
626
Skywest
SKYW
$4.18B
$617K 0.01%
6,159
-353
-5% -$36K
FFIC
627
DELISTED
Flushing Financial
FFIC
$597K 0.01%
+41,817
New +$666K
KTCC icon
628
Key Tronic
KTCC
$45.7M
$591K 0.01%
141,625
+12,023
+9% +$65.2K
NTRA icon
629
Natera
NTRA
$45.9B
$535K 0.01%
3,381
+627
+23% +$91.3K
PWP icon
630
Perella Weinberg Partners
PWP
$1.26B
$505K 0.01%
21,170
+1,707
+9% +$39.6K
RCKT icon
631
Rocket Pharmaceuticals
RCKT
$397M
$480K 0.01%
38,208
+26,365
+223% +$397K
ITCI
632
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$480K 0.01%
5,747
+1,065
+23% +$87.5K
IIIN icon
633
Insteel Industries
IIIN
$626M
$476K 0.01%
17,609
-57,248
-76% -$1.66M
SFBC
634
Sound Financial Bancorp
SFBC
$110M
$460K 0.01%
8,740
– –
CRAI icon
635
CRA International
CRAI
$1.06B
$444K 0.01%
2,372
-1,594
-40% -$303K
NUVL
636
DELISTED
Nuvalent
NUVL
$410K 0.01%
5,240
+640
+14% +$59.8K
BPMC
637
DELISTED
Blueprint Medicines
BPMC
$398K 0.01%
4,564
+748
+20% +$68.5K
MODV
638
DELISTED
ModivCare
MODV
$396K 0.01%
33,409
-45,719
-58% -$724K
SR icon
639
Spire
SR
$4.79B
$373K 0.01%
+5,500
New +$369K
ALNY icon
640
Alnylam Pharmaceuticals
ALNY
$29B
$361K 0.01%
1,535
-944
-38% -$248K
UEIC icon
641
Universal Electronics
UEIC
$71.6M
$359K 0.01%
32,593
+2,606
+9% +$26K
VSTM icon
642
Verastem
VSTM
$615M
$326K 0.01%
63,050
-553,720
-90% -$2.18M
AMTM
643
Amentum Holdings
AMTM
$5.97B
$325K 0.01%
+15,449
New +$399K
CYTK icon
644
Cytokinetics
CYTK
$10.5B
$302K 0.01%
6,423
+1,172
+22% +$60.9K
IWN icon
645
iShares Russell 2000 Value ETF
IWN
$14.5B
$295K 0.01%
+1,794
New +$306K
ABSI icon
646
Absci
ABSI
$1.53B
$270K 0.01%
102,995
+14,373
+16% +$50.6K
IVAC
647
DELISTED
Intevac Inc
IVAC
$253K 0.01%
74,435
-333,846
-82% -$1.05M
GEAR
648
DELISTED
Revelyst, Inc.
GEAR
$234K 0.01%
+12,168
New +$232K
SNA icon
649
Snap-on
SNA
$21.3B
$234K 0.01%
+688
New +$232K
ASYS icon
650
Amtech Systems
ASYS
$264M
$231K 0.01%
42,325
-53,786
-56% -$305K
24 25
26
27 28

Similar funds

GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
VDI
Vaughan David Investments Peoria, Illinois $4.73B AUM 19.55% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
SAMU
SONA Asset Management (US) New York $4.74B AUM 11.18% 1-Year Est. Return
JCM
Junto Capital Management New York $4.74B AUM 27.96% 1-Year Est. Return
DCP
Darsana Capital Partners New York $4.7B AUM 50.56% 1-Year Est. Return
Twin Tree Management
Twin Tree Management Dallas, Texas $4.75B AUM 58.16% 1-Year Est. Return
RC
Resolution Capital Sydney, NSW, Australia $4.76B AUM 10.22% 1-Year Est. Return

Kennedy Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Kennedy Capital Management held 752 positions worth $4.5B, down 0.58% from $4.53B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.

Kennedy Capital Management's Q4 2024 filing shows 65 new, 220 increased, 377 reduced and 83 closed positions. Its largest new stake was Boot Barn: 116,357 shares worth $17.7M. The largest sale was Stifel, an estimated $19.5M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 20% a quarter earlier, followed by Industrials and Healthcare.

  • Kennedy Capital Management's largest Q4 2024 buy was Boot Barn: 116,357 shares worth $17.7M.
  • Kennedy Capital Management added most to Mercury Systems in Q4 2024, an estimated $10.6M increase.
  • Kennedy Capital Management's biggest Q4 2024 reduction was Stifel, cutting an estimated $19.5M.
  • Kennedy Capital Management fully exited Phathom Pharmaceuticals in Q4 2024, selling an estimated $13.2M.
  • Kennedy Capital Management's ten largest holdings make up 8.7% of its $4.5B portfolio in Q4 2024.
  • Kennedy Capital Management opened 65 new positions and closed 83 in Q4 2024.
  • Kennedy Capital Management's portfolio value fell 0.58% quarter-over-quarter to $4.5B.

Based on Kennedy Capital Management's 13F filing for Q4 2024, filed 13 Feb 2025.